US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Tevogen Bio Holdings

7.48

0.0000

Post-market: 7.480.00000.00%16:10 EDT

Volume:8.85K

Turnover:65.74K

Market Cap:31.15M

PE:-0.93

High:7.50

Open:7.50

Low:7.00

Close:7.48

52wk High:75.50

52wk Low:4.14

Shares:4.16M

Float Shares:1.13M

Volume Ratio:0.98

T/O Rate:0.78%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-8.0804

EPS(LYR):-3.5022

ROE:--

ROA:-416.53%

PB:-1.83

PE(LYR):-2.14

Loading ...

Overview Company News Filings

Tevogen Bio Holdings Inc - Evaluating Acquisition of Sciometrix and Clinicus Platform for Long Covid Monitoring

THOMSON REUTERS

Tevogen accelerates TVGN 489 Long COVID program as HLA coverage reaches 65% of U.S. population

Tevogen appoints interim leaders across core business verticals

Tevogen names interim leaders for digital health, generics, contract research, biotech and AI verticals

Press Release: Tevogen Names Leadership Team to Execute Diversified Growth Strategy

Tevogen CEO says ‘actively evaluating potential acquisitions’

Tevogen Bio Explores Buyout To Boost Generics Platform

Benzinga_recent_news

NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 10:14 AM

Tevogen Bio Holdings Inc trading halted, news pending

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

Tevogen signs LOI to evaluate potential acquisition of Apozeal Pharmaceutical

Tevogen Bio Signs LOI to Evaluate Apozeal Pharmaceutical Acquisition

Tevogen Bio Holdings Inc - Actively Considering Other Transactions With a Focus on Life Sciences-Related Businesses

THOMSON REUTERS

Tevogen Bio Holdings approves 50-for-1 reverse stock split

Tevogen Bio Holdings Inc - Approves Reverse Stock Split at 50 for 1 Ratio

THOMSON REUTERS

Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital

Tevogen signs LoI to evaluate acquisition of contract research organization

Tevogen Signs LOI to Pursue CRO Acquisition

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization

THOMSON REUTERS

BRIEF-Tevogen Signs LOI To Evaluate Potential Acquisition Of Sciometrix

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TVGN/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TVGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGN\",,,,,undefined,":{"symbol":"TVGN","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings","latestPrice":7.48,"timestamp":1778270400000,"preClose":7.48,"halted":0,"volume":8849,"hourTrading":{"tag":"盘后","latestPrice":7.48,"preClose":7.48,"latestTime":"16:10 EDT","volume":6,"amount":44.88,"timestamp":1778271004260,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0,"floatShares":1133000,"shares":4164205,"eps":-8.080406,"marketStatus":"Market Closed","change":0,"latestTime":"05-08 16:00:00 EDT","open":7.5,"high":7.5,"low":7,"amount":65738.531216,"amplitude":0.066845,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.080406,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1778486400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":7.48,"postHourTrading":{"tag":"盘后","latestPrice":7.48,"preClose":7.48,"latestTime":"16:10 EDT","volume":6,"amount":44.88,"timestamp":1778271004260,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9840750905809761},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGN\",,,,,undefined,":{"symbol":"TVGN","floatShares":1133000,"roa":"-416.53%","roe":"--","lyrEps":-3.50225,"volumeRatio":0.9840750905809761,"shares":4164205,"dividePrice":0,"high":7.5,"amplitude":0.066845,"preClose":7.48,"low":7,"week52Low":4.1353,"pbRate":"-1.83","week52High":75.5,"institutionHeld":0,"latestPrice":7.48,"eps":-8.080406,"divideRate":0,"volume":8849,"delay":0,"ttmEps":-8.080406,"open":7.5,"prevYearClose":16.555,"prevWeekClose":6.66,"prevMonthClose":6.64,"prevQuarterClose":4.52,"fiveDayClose":6.66,"twentyDayClose":5.73,"sixtyDayClose":12.745},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TVGN\",params:#limit:5,,,undefined,":[{"date":"2026-03-31","symbol":"TVGN","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774987200000,"name":null,"time":"Post Market","dateTimestamp":1774929600000,"actualEps":null},{"market":"US","date":"2026-03-06","symbol":"TVGN","defaultRemindTime":1772807400000,"type":"split","dateTimestamp":1772773200000,"forFactor":50,"toFactor":1,"ratio":50},{"market":"US","date":"2025-11-14","symbol":"TVGN","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-0.03},{"market":"US","date":"2025-08-14","symbol":"TVGN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-05-14","symbol":"TVGN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TVGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TVGN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TVGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TVGN","date":"2026-05-08","current":-0.925696,"percent":0.925094,"low":-87.683882,"twenty":-25.699053,"median":-6.570165,"eighty":-2.487144,"high":-0.559471,"avg":-13.881841,"sd":15.119912,"marketCap":31148253},"quantilePoints":[{"date":"2024-03-01","current":-58.029616,"twenty":-57.969868,"median":-57.58151,"eighty":-55.109463,"marketCap":1279054027},{"date":"2024-03-08","current":-55.116932,"twenty":-57.969868,"median":-57.3948,"eighty":-55.049716,"marketCap":1214854404},{"date":"2024-03-15","current":-48.544723,"twenty":-57.715942,"median":-55.116932,"eighty":-49.664986,"marketCap":1069993717},{"date":"2024-03-22","current":-31.890149,"twenty":-57.596447,"median":-52.465643,"eighty":-44.108482,"marketCap":702903564},{"date":"2024-03-28","current":-25.919148,"twenty":-57.357457,"median":-49.38492,"eighty":-32.983824,"marketCap":571294337},{"date":"2024-04-05","current":-25.392625,"twenty":-55.998205,"median":-48.543977,"eighty":-28.607629,"marketCap":559689021},{"date":"2024-04-12","current":-18.446995,"twenty":-55.146806,"median":-35.064227,"eighty":-23.267262,"marketCap":406597612},{"date":"2024-04-19","current":-15.833048,"twenty":-54.915285,"median":-32.71989,"eighty":-19.118705,"marketCap":348982566},{"date":"2024-04-26","current":-6.348156,"twenty":-53.503754,"median":-29.329228,"eighty":-17.595595,"marketCap":139922255},{"date":"2024-05-03","current":-7.365355,"twenty":-52.428301,"median":-25.919148,"eighty":-15.026459,"marketCap":162342739},{"date":"2024-05-10","current":-2.698495,"twenty":-50.822591,"median":-23.061357,"eighty":-9.708944,"marketCap":163198734},{"date":"2024-05-17","current":-2.422494,"twenty":-49.291565,"median":-20.164731,"eighty":-7.316959,"marketCap":146506832},{"date":"2024-05-24","current":-2.231961,"twenty":-48.694091,"median":-18.372311,"eighty":-2.71254,"marketCap":134983822},{"date":"2024-05-31","current":-2.106753,"twenty":-48.544425,"median":-17.961548,"eighty":-2.656034,"marketCap":127411559},{"date":"2024-06-07","current":-8.033143,"twenty":-47.558444,"median":-17.550785,"eighty":-2.656034,"marketCap":148265257},{"date":"2024-06-14","current":-7.903098,"twenty":-44.108482,"median":-15.833048,"eighty":-2.68298,"marketCap":145865070},{"date":"2024-06-21","current":-6.795171,"twenty":-36.221832,"median":-12.47226,"eighty":-2.696046,"marketCap":125416385},{"date":"2024-06-28","current":-6.570165,"twenty":-35.295748,"median":-12.322891,"eighty":-2.697026,"marketCap":121263525},{"date":"2024-07-05","current":-6.173255,"twenty":-33.757254,"median":-8.033143,"eighty":-2.703177,"marketCap":113937879},{"date":"2024-07-12","current":-6.299258,"twenty":-33.071802,"median":-7.830197,"eighty":-2.721904,"marketCap":116263481},{"date":"2024-07-15","current":-6.435162,"twenty":-32.983824,"median":-7.830197,"eighty":-2.721904,"marketCap":118771808},{"date":"2024-08-02","current":-5.57114,"twenty":-32.895846,"median":-7.830197,"eighty":-2.721904,"marketCap":102824824},{"date":"2024-08-09","current":-5.526139,"twenty":-32.222045,"median":-7.468419,"eighty":-3.563104,"marketCap":101994252},{"date":"2024-08-16","current":-20.612899,"twenty":-30.545833,"median":-7.468046,"eighty":-4.127144,"marketCap":122353801},{"date":"2024-08-23","current":-17.275162,"twenty":-29.265149,"median":-7.830197,"eighty":-4.681198,"marketCap":102541700},{"date":"2024-08-30","current":-14.308285,"twenty":-28.407028,"median":-7.866648,"eighty":-5.281333,"marketCap":84930944},{"date":"2024-09-06","current":-12.936966,"twenty":-27.171154,"median":-9.617885,"eighty":-5.454137,"marketCap":76791088},{"date":"2024-09-13","current":-14.230663,"twenty":-25.708539,"median":-12.097501,"eighty":-5.499138,"marketCap":84470197},{"date":"2024-09-20","current":-12.649478,"twenty":-24.871927,"median":-12.454498,"eighty":-5.544139,"marketCap":75084620},{"date":"2024-09-27","current":-11.784139,"twenty":-23.267262,"median":-12.36199,"eighty":-5.658262,"marketCap":69948149},{"date":"2024-10-04","current":-8.756889,"twenty":-21.942215,"median":-12.240382,"eighty":-5.887588,"marketCap":51979034},{"date":"2024-10-11","current":-9.208245,"twenty":-21.329829,"median":-12.040003,"eighty":-6.069393,"marketCap":54658190},{"date":"2024-10-18","current":-39.673363,"twenty":-24.871927,"median":-12.127687,"eighty":-6.141394,"marketCap":235492672},{"date":"2024-10-25","current":-73.596963,"twenty":-29.393307,"median":-12.327491,"eighty":-6.173255,"marketCap":436855971},{"date":"2024-10-31","current":-70.722082,"twenty":-31.779361,"median":-12.436737,"eighty":-6.180635,"marketCap":419791285},{"date":"2024-11-08","current":-32.773648,"twenty":-33.757254,"median":-12.633666,"eighty":-6.224556,"marketCap":194537424},{"date":"2024-11-15","current":-42.548244,"twenty":-38.983392,"median":-12.936966,"eighty":-6.285578,"marketCap":252557358},{"date":"2024-11-22","current":-36.270609,"twenty":-39.155884,"median":-13.187081,"eighty":-6.299438,"marketCap":287084045},{"date":"2024-11-29","current":-28.972255,"twenty":-38.235922,"median":-13.602501,"eighty":-6.300158,"marketCap":229317133},{"date":"2024-12-06","current":-23.222036,"twenty":-37.373458,"median":-13.816575,"eighty":-6.348156,"marketCap":183803809},{"date":"2024-12-13","current":-22.337387,"twenty":-36.270609,"median":-14.269474,"eighty":-6.435162,"marketCap":176801759},{"date":"2024-12-20","current":-21.33331,"twenty":-36.221832,"median":-15.004006,"eighty":-6.508963,"marketCap":168854432},{"date":"2024-12-27","current":-23.222036,"twenty":-35.303209,"median":-15.833048,"eighty":-6.557925,"marketCap":183803809},{"date":"2025-01-03","current":-23.443198,"twenty":-34.373394,"median":-17.065337,"eighty":-6.580965,"marketCap":185554321},{"date":"2025-01-10","current":-28.52993,"twenty":-33.790638,"median":-17.550785,"eighty":-6.670967,"marketCap":225816108},{"date":"2025-01-17","current":-26.760632,"twenty":-33.439732,"median":-17.684618,"eighty":-6.873653,"marketCap":211812008},{"date":"2025-01-24","current":-30.52039,"twenty":-33.171426,"median":-18.032197,"eighty":-7.005548,"marketCap":241570720},{"date":"2025-01-31","current":-29.635741,"twenty":-33.528197,"median":-18.446995,"eighty":-7.075423,"marketCap":234568670},{"date":"2025-02-07","current":-31.405039,"twenty":-33.171426,"median":-19.295444,"eighty":-7.138439,"marketCap":248572770},{"date":"2025-02-14","current":-34.501311,"twenty":-33.892862,"median":-20.164731,"eighty":-7.192457,"marketCap":273079945},{"date":"2025-02-21","current":-34.280148,"twenty":-34.280148,"median":-20.612899,"eighty":-7.244366,"marketCap":271329432},{"date":"2025-02-28","current":-27.645281,"twenty":-34.280148,"median":-21.570546,"eighty":-7.365355,"marketCap":218814058},{"date":"2025-03-07","current":-24.327847,"twenty":-34.058986,"median":-22.031836,"eighty":-7.370735,"marketCap":192556371},{"date":"2025-03-14","current":-24.54901,"twenty":-33.906622,"median":-22.226806,"eighty":-7.443187,"marketCap":194306884},{"date":"2025-03-21","current":-25.875983,"twenty":-33.837824,"median":-22.558549,"eighty":-7.452187,"marketCap":204809958},{"date":"2025-03-28","current":-26.53947,"twenty":-33.616662,"median":-23.000874,"eighty":-7.454567,"marketCap":210061496},{"date":"2025-04-04","current":-13.396106,"twenty":-33.174337,"median":-23.222036,"eighty":-7.467672,"marketCap":183893433},{"date":"2025-04-11","current":-13.396106,"twenty":-33.15978,"median":-22.669131,"eighty":-7.468419,"marketCap":183893433},{"date":"2025-04-17","current":-13.664028,"twenty":-32.994496,"median":-22.447968,"eighty":-7.468419,"marketCap":187571301},{"date":"2025-04-25","current":-13.530067,"twenty":-32.809553,"median":-22.063146,"eighty":-7.757841,"marketCap":185732367},{"date":"2025-05-02","current":-13.10675,"twenty":-32.74034,"median":-21.917772,"eighty":-7.830197,"marketCap":179921334},{"date":"2025-05-09","current":-14.601755,"twenty":-32.722315,"median":-21.231576,"eighty":-7.830197,"marketCap":200443841},{"date":"2025-05-16","current":-5.980818,"twenty":-32.552659,"median":-20.228412,"eighty":-7.830197,"marketCap":211477447},{"date":"2025-05-23","current":-6.396875,"twenty":-32.510851,"median":-19.566511,"eighty":-7.465051,"marketCap":226188922},{"date":"2025-05-30","current":-6.968954,"twenty":-32.378153,"median":-18.686729,"eighty":-7.414206,"marketCap":246417200},{"date":"2025-06-06","current":-7.333003,"twenty":-32.156991,"median":-18.297627,"eighty":-7.218412,"marketCap":259289740},{"date":"2025-06-13","current":-6.604904,"twenty":-32.068526,"median":-17.743768,"eighty":-7.033891,"marketCap":233544659},{"date":"2025-06-20","current":-6.240854,"twenty":-31.997175,"median":-17.550785,"eighty":-6.875341,"marketCap":220672119},{"date":"2025-06-27","current":-6.155194,"twenty":-31.696105,"median":-17.17025,"eighty":-6.729721,"marketCap":217643250},{"date":"2025-07-03","current":-6.46817,"twenty":-31.405039,"median":-16.307839,"eighty":-6.667312,"marketCap":228709856},{"date":"2025-07-11","current":-6.682997,"twenty":-31.405039,"median":-15.62498,"eighty":-6.591513,"marketCap":236305988},{"date":"2025-07-18","current":-6.792554,"twenty":-31.391273,"median":-15.003822,"eighty":-6.576385,"marketCap":240179856},{"date":"2025-07-25","current":-5.861317,"twenty":-31.327857,"median":-14.601755,"eighty":-6.518995,"marketCap":207251973},{"date":"2025-08-01","current":-5.419253,"twenty":-31.139644,"median":-14.400813,"eighty":-6.46817,"marketCap":191620913},{"date":"2025-08-08","current":-4.760814,"twenty":-30.52039,"median":-14.230663,"eighty":-6.437906,"marketCap":168338962},{"date":"2025-08-15","current":-6.178593,"twenty":-30.431925,"median":-14.065911,"eighty":-6.351294,"marketCap":192770965},{"date":"2025-08-22","current":-5.701959,"twenty":-30.042206,"median":-13.93195,"eighty":-6.299316,"marketCap":177900062},{"date":"2025-08-29","current":-5.69061,"twenty":-29.890394,"median":-13.807282,"eighty":-6.244587,"marketCap":177545993},{"date":"2025-09-05","current":-5.543711,"twenty":-29.856904,"median":-13.784336,"eighty":-6.173255,"marketCap":172962765},{"date":"2025-09-12","current":-5.571452,"twenty":-29.856904,"median":-13.664028,"eighty":-6.13684,"marketCap":173828267},{"date":"2025-09-19","current":-5.1793,"twenty":-29.856904,"median":-13.535379,"eighty":-6.076457,"marketCap":161593212},{"date":"2025-09-26","current":-4.949179,"twenty":-29.649623,"median":-13.530067,"eighty":-5.980818,"marketCap":154413477},{"date":"2025-10-03","current":-4.913873,"twenty":-29.635741,"median":-13.396106,"eighty":-5.916096,"marketCap":153311929},{"date":"2025-10-10","current":-4.653489,"twenty":-29.635741,"median":-13.224454,"eighty":-5.861317,"marketCap":145188009},{"date":"2025-10-17","current":-4.550723,"twenty":-29.193417,"median":-13.114788,"eighty":-5.799682,"marketCap":141981717},{"date":"2025-10-24","current":-4.009781,"twenty":-29.008833,"median":-12.942716,"eighty":-5.720783,"marketCap":125104422},{"date":"2025-10-31","current":-3.785965,"twenty":-28.972255,"median":-12.845429,"eighty":-5.69061,"marketCap":118121392},{"date":"2025-11-07","current":-2.958159,"twenty":-28.972255,"median":-12.617854,"eighty":-5.578387,"marketCap":92294017},{"date":"2025-11-14","current":-2.801172,"twenty":-28.52993,"median":-12.480725,"eighty":-5.543081,"marketCap":87396061},{"date":"2025-11-21","current":-2.645367,"twenty":-28.52993,"median":-12.36199,"eighty":-5.481138,"marketCap":82118544},{"date":"2025-11-28","current":-2.823943,"twenty":-28.353,"median":-12.322891,"eighty":-5.461498,"marketCap":87661993},{"date":"2025-12-05","current":-2.699132,"twenty":-28.308768,"median":-12.068752,"eighty":-5.409064,"marketCap":83787539},{"date":"2025-12-12","current":-2.752257,"twenty":-28.131838,"median":-11.442028,"eighty":-5.291239,"marketCap":85436666},{"date":"2025-12-19","current":-2.436707,"twenty":-28.02218,"median":-10.752057,"eighty":-5.153265,"marketCap":75641252},{"date":"2025-12-26","current":-2.533996,"twenty":-27.789498,"median":-9.196745,"eighty":-5.02307,"marketCap":78661339},{"date":"2026-01-02","current":-2.119238,"twenty":-27.645281,"median":-8.929381,"eighty":-4.949936,"marketCap":65786232},{"date":"2026-01-09","current":-2.496233,"twenty":-27.556816,"median":-8.756889,"eighty":-4.820059,"marketCap":77489069},{"date":"2026-01-16","current":-2.089155,"twenty":-27.424119,"median":-7.962008,"eighty":-4.663072,"marketCap":64852390},{"date":"2026-01-23","current":-2.37218,"twenty":-27.424119,"median":-7.830197,"eighty":-4.518443,"marketCap":73638158},{"date":"2026-01-30","current":-1.936804,"twenty":-27.379887,"median":-7.468419,"eighty":-4.421855,"marketCap":60123058},{"date":"2026-02-06","current":-1.818364,"twenty":-27.114492,"median":-7.46112,"eighty":-4.143606,"marketCap":56446391},{"date":"2026-02-13","current":-1.687878,"twenty":-26.7164,"median":-7.443187,"eighty":-3.975483,"marketCap":52395793},{"date":"2026-02-20","current":-1.94106,"twenty":-26.53947,"median":-7.370735,"eighty":-3.883057,"marketCap":60255162},{"date":"2026-02-27","current":-1.878738,"twenty":-26.53947,"median":-7.288685,"eighty":-3.499732,"marketCap":58320548},{"date":"2026-03-06","current":-1.006884,"twenty":-26.53947,"median":-7.128179,"eighty":-2.963203,"marketCap":31256100},{"date":"2026-03-13","current":-0.832034,"twenty":-26.318308,"median":-6.980165,"eighty":-2.886029,"marketCap":25828351},{"date":"2026-03-20","current":-0.692493,"twenty":-26.097145,"median":-6.902112,"eighty":-2.807942,"marketCap":21496637},{"date":"2026-03-27","current":-0.620766,"twenty":-26.097145,"median":-6.804051,"eighty":-2.752257,"marketCap":19270055},{"date":"2026-04-02","current":-0.710003,"twenty":-26.097145,"median":-6.776739,"eighty":-2.720294,"marketCap":18655638},{"date":"2026-04-10","current":-0.928709,"twenty":-25.954747,"median":-6.737776,"eighty":-2.69278,"marketCap":24402241},{"date":"2026-04-17","current":-1.007951,"twenty":-25.884616,"median":-6.708918,"eighty":-2.639975,"marketCap":26484343},{"date":"2026-04-24","current":-1.110965,"twenty":-25.875983,"median":-6.656911,"eighty":-2.586737,"marketCap":29191077},{"date":"2026-05-01","current":-1.052326,"twenty":-25.875983,"median":-6.596535,"eighty":-2.533996,"marketCap":27650321},{"date":"2026-05-08","current":-1.185452,"twenty":-25.699053,"median":-6.570165,"eighty":-2.487144,"marketCap":31148253}],"updateTime":1778411318128},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TVGN\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618978368","title":"Tevogen Bio Holdings Inc - Evaluating Acquisition of Sciometrix and Clinicus Platform for Long Covid Monitoring","url":"https://stock-news.laohu8.com/highlight/detail?id=2618978368","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618978368?lang=en_us&edition=fundamental","pubTime":"2026-03-12 03:15","pubTimestamp":1773256542,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nFWN3ZZ11G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGNW","BK4139","TVGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618978365","title":"Tevogen accelerates TVGN 489 Long COVID program as HLA coverage reaches 65% of U.S. population","url":"https://stock-news.laohu8.com/highlight/detail?id=2618978365","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618978365?lang=en_us&edition=fundamental","pubTime":"2026-03-12 03:15","pubTimestamp":1773256525,"startTime":"0","endTime":"0","summary":"Tevogen said it is accelerating its Biotech and Digital Health verticals to move investigational TVGN 489 into its next clinical phase. Tevogen cited proof-of-concept data showing 100% of treated high-risk patients did not develop Long COVID. The company said identifying five additional HLA targets expanded potential eligibility for TVGN 489 to about 65% of the U.S. population. Tevogen also said it is evaluating the acquisition of Sciometrix and its Clinicus platform for real-world monitoring and data collection in future trials.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL2CYkwn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4588","BK4585","IE00BGHQF748.EUR","SG9999014005.SGD","IE00BKPKM429.USD","NDAQ","SG9999014039.USD","TVGN","BK4139","SG9999014013.SGD","LU2210150020.SGD","LU2095319765.USD","IE00B64PRP62.GBP","LU2210149790.SGD","LU0314104364.USD","SG9999014021.USD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618360625","title":"Tevogen appoints interim leaders across core business verticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2618360625","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618360625?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:51","pubTimestamp":1773057082,"startTime":"0","endTime":"0","summary":"Tevogen (TVGN) announced the appointment of interim leaders across its core business verticals to execute the first phase of its diversified growth...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-appoints-interim-leaders-across-core-business-verticals-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-appoints-interim-leaders-across-core-business-verticals-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TVGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618623154","title":"Tevogen names interim leaders for digital health, generics, contract research, biotech and AI verticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2618623154","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618623154?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:45","pubTimestamp":1773056720,"startTime":"0","endTime":"0","summary":"Tevogen named interim leaders across five business verticals as part of its diversified growth strategy. Digital Health will be led by Arpita Patel and Wojtek Stobinski, while Generics will be led by Sadiq Khan and David Banko. William Keane was designated to lead Contract Research, Lori Grosso to lead Biotech, and Mittul Mehta to lead Artificial Intelligence. The company said it is evaluating strategic opportunities expected to operate as subsidiaries and collectively generate more than 50 million in annual revenue.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDLbJw4CL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","BK4588","SG9999014021.USD","IE00B64PRP62.GBP","LU0314104364.USD","BK4585","BK4112","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014013.SGD","BK4139","TVGN","NDAQ","LU2210150020.SGD","LU2210149790.SGD","LU2095319765.USD","IE00BGHQF748.EUR","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618125623","title":"Press Release: Tevogen Names Leadership Team to Execute Diversified Growth Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2618125623","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618125623?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:45","pubTimestamp":1773056700,"startTime":"0","endTime":"0","summary":"WARREN, N.J., March 09, 2026  -- Tevogen   today announced the appointment of interim leaders across its core business verticals to execute the first phase of its diversified growth strategy.In this first phase, Tevogen is evaluating strategic opportunities that, if completed, are expected to operate as subsidiaries of the Company and could collectively generate annual revenues exceeding $50 million. The Company expects these transactions to close by the second quarter of 2026, subject to customary due diligence and definitive agreements.-- Digital Health: Arpita Patel and Wojtek Stobinski. Tevogen Bio, the company's lead initiative, has completed a proof-of-concept clinical trial demonstrating the potential of its single-HLA-restricted, genetically unmodified allogeneic T cells. Tevogen Bio's pipeline spans virology, oncology, and neurology, with programs built on the company's proprietary ExacTcell platform.This press release contains certain forward-looking statements, including wit","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN","BK4604","BK4139","BK4120","BK4555","03160","BK4588","TM","BK4585","BK4099","TISI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617302256","title":"Tevogen CEO says ‘actively evaluating potential acquisitions’","url":"https://stock-news.laohu8.com/highlight/detail?id=2617302256","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617302256?lang=en_us&edition=fundamental","pubTime":"2026-03-07 04:45","pubTimestamp":1772829938,"startTime":"0","endTime":"0","summary":"Dr. Ryan Saadi, Founder & CEO Tevogen (TVGN), sent the following letter to shareholders: “Dear Shareholders, As we continue executing on Tevogen’s ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-ceo-says-actively-evaluating-potential-acquisitions-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-ceo-says-actively-evaluating-potential-acquisitions-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TVGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617632300","title":"Tevogen Bio Explores Buyout To Boost Generics Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2617632300","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617632300?lang=en_us&edition=fundamental","pubTime":"2026-03-07 01:42","pubTimestamp":1772818920,"startTime":"0","endTime":"0","summary":"Tevogen stock swings after Apozeal acquisition talks and a 50-for-1 reverse split as TVGN trades near lows.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/06/MA.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/06/MA.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/m-a/26/03/51104662/tevogen-bio-explores-buyout-to-boost-generics-platform","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/m-a/26/03/51104662/tevogen-bio-explores-buyout-to-boost-generics-platform","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["TVGN","SMA","BK4139","BK4217"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617639862","title":"NASDAQ TRADE HALT CONTINUES  VOLATILITY TRADING PAUSE AT 10:14 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2617639862","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617639862?lang=en_us&edition=fundamental","pubTime":"2026-03-06 23:14","pubTimestamp":1772810062,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT CONTINUES  VOLATILITY TRADING PAUSE AT 10:14 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nAQN2LP6KA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TVGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617038145","title":"Tevogen Bio Holdings Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2617038145","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617038145?lang=en_us&edition=fundamental","pubTime":"2026-03-06 08:51","pubTimestamp":1772758272,"startTime":"0","endTime":"0","summary":"19:50 EST Tevogen (TVGN) Bio Holdings Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-bio-holdings-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-bio-holdings-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TVGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617508450","title":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:50 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2617508450","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617508450?lang=en_us&edition=fundamental","pubTime":"2026-03-06 08:50","pubTimestamp":1772758200,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:50 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nAQN2LP04G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TVGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617736865","title":"Tevogen signs LOI to evaluate potential acquisition of Apozeal Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=2617736865","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617736865?lang=en_us&edition=fundamental","pubTime":"2026-03-06 04:00","pubTimestamp":1772740817,"startTime":"0","endTime":"0","summary":"Tevogen (TVGN) announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent to evaluate a potential transaction with Ap...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-signs-loi-to-evaluate-potential-acquisition-of-apozeal-pharmaceutical-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-signs-loi-to-evaluate-potential-acquisition-of-apozeal-pharmaceutical-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TVGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617573809","title":"Tevogen Bio Signs LOI to Evaluate Apozeal Pharmaceutical Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2617573809","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617573809?lang=en_us&edition=fundamental","pubTime":"2026-03-06 03:50","pubTimestamp":1772740214,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc. has signed a non-exclusive, non-binding letter of intent to evaluate a potential acquisition of Apozeal Pharmaceutical Inc., aiming to expand its Tevogen Generics strategy. Tevogen said Apozeal would bring an established generics platform, including 11 FDA-approved ANDA products for the U.S. market, additional ANDAs awaiting approval, and other generic products in development, subject to due diligence and definitive agreements.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDL1JjzSX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","SG9999014005.SGD","IE00BKPKM429.USD","SG9999014039.USD","LU2095319765.USD","BK4585","LU0314104364.USD","LU2210150020.SGD","IE00B64PRP62.GBP","BK4139","NDAQ","SG9999014013.SGD","SG9999014021.USD","TVGN","LU2210149790.SGD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617573877","title":"Tevogen Bio Holdings Inc - Actively Considering Other Transactions With a Focus on Life Sciences-Related Businesses","url":"https://stock-news.laohu8.com/highlight/detail?id=2617573877","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617573877?lang=en_us&edition=fundamental","pubTime":"2026-03-06 03:50","pubTimestamp":1772740200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nTUA6VBZZV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGN","TVGNW","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616558608","title":"Tevogen Bio Holdings approves 50-for-1 reverse stock split","url":"https://stock-news.laohu8.com/highlight/detail?id=2616558608","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616558608?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:01","pubTimestamp":1772629319,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc. said its board approved a 1-for-50 reverse stock split after shareholders authorized it on Feb. 19, 2026. The company expects the split to take effect at 12:01 a.m. on March 6, 2026, with shares trading on a split-adjusted basis the same day under the symbol TVGN and a new CUSIP 88165K 200. Tevogen said the move is intended to help regain compliance with Nasdaq’s $1.00 minimum bid price requirement, and fractional shares will be paid in cash.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL3WLLRN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","NDAQ","LU2210149790.SGD","SG9999014021.USD","LU2095319765.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","SG9999014005.SGD","LU0314104364.USD","TVGN","BK4588","SG9999014013.SGD","BK4112","IE00BGHQF748.EUR","LU2210150020.SGD","SG9999014039.USD","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616558318","title":"Tevogen Bio Holdings Inc - Approves Reverse Stock Split at 50 for 1 Ratio","url":"https://stock-news.laohu8.com/highlight/detail?id=2616558318","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616558318?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:00","pubTimestamp":1772629203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nTUA5FG3QH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGN","TVGNW","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616371975","title":"Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2616371975","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616371975?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:02","pubTimestamp":1772571720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TVGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 03, 2026 16:02 ET (21:02 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614861731","title":"Tevogen signs LoI to evaluate acquisition of contract research organization","url":"https://stock-news.laohu8.com/highlight/detail?id=2614861731","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614861731?lang=en_us&edition=fundamental","pubTime":"2026-02-28 03:25","pubTimestamp":1772220358,"startTime":"0","endTime":"0","summary":"Tevogen (TVGN) announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent to evaluate a potential transaction with a ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-signs-loi-to-evaluate-acquisition-of-contract-research-organization-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-signs-loi-to-evaluate-acquisition-of-contract-research-organization-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TVGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614686164","title":"Tevogen Signs LOI to Pursue CRO Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2614686164","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614686164?lang=en_us&edition=fundamental","pubTime":"2026-02-28 03:20","pubTimestamp":1772220020,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc. has signed a non-exclusive, non-binding letter of intent to evaluate a potential acquisition of an unnamed global contract research organization, a deal that the company said could expand its clinical development capabilities and add revenue-generating services, subject to due diligence and definitive agreements.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nNDL6FZyvW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014021.USD","BK4112","BK4585","IE00BGHQF748.EUR","LU2095319765.USD","NDAQ","BK4588","SG9999014005.SGD","LU0314104364.USD","SG9999014013.SGD","BK4139","LU2210149790.SGD","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","TVGN","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614861617","title":"Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization","url":"https://stock-news.laohu8.com/highlight/detail?id=2614861617","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614861617?lang=en_us&edition=fundamental","pubTime":"2026-02-28 03:20","pubTimestamp":1772220000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nTUA6Z07NH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGN","TVGNW","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614020614","title":"BRIEF-Tevogen Signs LOI To Evaluate Potential Acquisition Of Sciometrix","url":"https://stock-news.laohu8.com/highlight/detail?id=2614020614","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614020614?lang=en_us&edition=fundamental","pubTime":"2026-02-27 02:55","pubTimestamp":1772132151,"startTime":"0","endTime":"0","summary":"BRIEF-Tevogen Signs LOI To Evaluate Potential Acquisition Of SciometrixFeb 26 (Reuters) - Tevogen Bio Holdings Inc TVGN.O:TEVOGEN SIGNS LETTER OF INTENT TO EVALUATE POTENTIAL ACQUISITION OF SCIOMETRIX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nTUA5DM9F4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":57,"code":"91000000","status":"200"}]}}